BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD
Published March 13, 2019 · Recall initiated: February 28, 2019
Summary
FDA records drug Class III recall D-0519-2019, published March 13, 2019 and initiated February 28, 2019. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: a) 3,072 bottles; b) 2,688 bottles; Lot: a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; 9-monthstability timepoint
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Distributor
- Product was distributed to one customer who may have further distributed the product.
- Lot
- a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAProchlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc.,January 11, 2023
- FDAIrbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAIrbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee-August 3, 2022
- FDAMethylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant CadistaApril 13, 2022
- FDATopical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mLMarch 13, 2019
- FDAHermes NC PTA Balloon Dilatation Catheter The balloon dilatation catheter is intended to dilate stenoses inMarch 6, 2019
Questions about this recall
Was BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD recalled?
Yes. FDA published recall D-0519-2019 on March 13, 2019. Reported hazard: Failed Dissolution Specifications; 9-monthstability timepoint
What should I do if I have this product?
Voluntary: Firm initiated · Letter